The ACS's mission-driven venture capital fund

BrightEdge exists to accelerate the American Cancer Society's mission for a world without cancer.

About

We invest in the development of life-saving therapeutics

BrightEdge invests in the most promising for-profit oncology companies bringing innovative treatments to market.

Portfolio

Fighting for a World Without Cancer

BrightEdge is led by a world-class team of investors, operators, and entrepreneurs to ensure the best cancer innovations are brought to market.

Team

News